Quality of life and disability have been compared in patients with ulcerative colitis who were undergoing one of the two current major treatments of choice, proctocolectomy or anti-TNF therapy. The only significant differences between the two groups were increased use of antidiarrhoeal medication and stool frequency in those who underwent surgery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Meijs, S. et al. Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. J. Crohns Colitis http://dx.doi.org/10.1016/j.crohns.2013.12.011.
Oussalah, A. et al. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am. J. Gastroenterol. 105, 2617–2625 (2010).
Francone, T. D. & Champagne, B. Considerations and complications in patients undergoing ileal pouch anal anastomosis. Surg. Clin. North Am. 93, 107–143.
Casellas, F. et al. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment. J. Crohns Colitis 6, 881–886 (2012).
Feagan, B. G. et al. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am. J. Gastroenterol. 102, 794–802 (2007).
Heikens, J. T. et al. Quality of life and health status before and after ileal pouch-anal anastomosis for ulcerative colitis. Br. J. Surg. 99, 263–269 (2012).
Cohen, R. D., Brodsky, A. L. & Hanauer, S. B. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm. Bowel Dis. 5, 1–10 (1999).
Park, K. T. et al. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann. Surg. 256, 117–124 (2012).
Steenholdt, C. et al. Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study. Scand. J. Gastroenterol. 47, 518–527 (2012).
Peyrin-Biroulet, L. et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61, 241–247 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kobayashi, T., Hibi, T. Which makes patients happier, surgery or anti-TNF therapy?. Nat Rev Gastroenterol Hepatol 11, 272–273 (2014). https://doi.org/10.1038/nrgastro.2014.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2014.28
